New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareSNAP-8 vs Survodutide

SNAP-8 vs Survodutide

Side-by-side comparison of key properties, dosing, and research.

Skin & Cosmetic
SNAP-8
GLP-1 / Weight Loss Agonists
Survodutide
Summary
SNAP-8 is a synthetic octapeptide cosmetic ingredient that reduces the depth of expression lines and wrinkles by competitively inhibiting the SNARE complex involved in acetylcholine release at neuromuscular junctions, providing a topical 'Botox-like' effect.
Survodutide is a once-weekly GLP-1/glucagon dual receptor agonist developed by Boehringer Ingelheim and Zealand Pharma. Phase 2 trials demonstrated up to 18.7% body weight reduction at 46 weeks, among the highest reported for a dual agonist. It is being studied for obesity and MASH (metabolic dysfunction-associated steatohepatitis), where the glucagon component drives hepatic fat clearance.
Half-Life
N/A — topical application; local effect duration depends on formulation
~7 days
Admin Route
Topical
SubQ
Research
Typical Dose
3–10% concentration in formulation
0.6 mg → 2.4 mg → 4.8 mg → 6 mg
Frequency
1–2x daily
Once weekly
Key Benefits
  • Reduces depth of dynamic expression wrinkles
  • Smooths forehead lines, crow's feet, glabellar lines
  • Non-invasive topical Botox alternative
  • Can be incorporated into serums, creams, eye contour products
  • Reduces muscle contraction without paralysis
  • Improves skin texture and firmness over time
  • Complements other anti-aging peptides (Argireline, Matrixyl)
  • Up to 18.7% body weight reduction at 46 weeks (Phase 2)
  • Strong MASH activity — Phase 3 SYNCHRONIZE-NASH trials ongoing
  • Reduces hepatic fat content via glucagon receptor-driven liver oxidation
  • Once-weekly subcutaneous injection
  • Greater weight loss potential than GLP-1 monotherapy
  • Improvements in liver fibrosis markers in early data
Side Effects
  • Generally excellent tolerability
  • Rare: mild redness in sensitive individuals
  • Not suitable for injection (topical use only)
  • Nausea (most common during titration)
  • Vomiting
  • Diarrhea
  • Decreased appetite
  • +3 more
Stacks With